Neonatal hyperbilirubinemia is frequent and severe in Japanese infants. Although the G71R mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene is associated with severe neonatal hyperbilirubinemia in this population, it accounts for only half of the neonates with severe hyperbilirubinemia. It was suggested that increased bilirubin production would also be associated with severe neonatal hyperbilirubinemia in Japanese infants. To elucidate the genetic factors causing severe hyperbilirubinemia in these patients, we studied two notable factors associated with bilirubin production: heme oxygenase-1, a key enzyme of heme metabolism, and fetal Hb composition, a factor possibly associated with heme load in neonates. We first determined the sequences of promoter and all coding regions of the heme oxygenase-1 gene in Japanese neonates who had undergone phototherapy, but found no mutation except for the polymorphic (GT) n repeats in the promoter region. These repeats modulate the transcription of the heme oxygenase-1 gene, and the longer repeat sequences are known to reduce the transcription. We detected a significant difference in the allele frequencies of each number of (GT) n repeats between Japanese and German populations. However, we could not find a relation between those polymorphisms and neonatal hyperbilirubinemia. We next analyzed the state of Hb switching of the ␥-to -globin chain and the phenotype of ␥-globin chain isoforms in cord blood. We found no relation between fetal Hb composition and neonatal hyperbilirubinemia. Further studies are required to elucidate genetic or environmental factors in neonatal hyperbilirubinemia in Japanese infants. (Pediatr Res 54: 165-171, 2003) Abbreviations B-UGT, bilirubin uridine diphosphate-glucuronosyltransferase (EC 2.4.1.17) HO-1, heme oxygenase-1 (EC 1.14.99.3) CO, carbon monoxide HbF, fetal hemoglobin TCBR, transcutaneous bilirubinometer reading Unconjugated hyperbilirubinemia in the neonate is a physiologic and transitional phenomenon that is very common. Physiologic unconjugated hyperbilirubinemia of the neonate is called neonatal hyperbilirubinemia or neonatal jaundice. The term physiologic means that the neonate has no evidence of diseases causing unconjugated hyperbilirubinemia such as hemolytic anemias and does not carry variable risk factors associated with neonatal unconjugated hyperbilirubinemia such as maternal diabetes, prematurity, and so on (1).Bilirubin production is increased in the neonate because of larger erythrocyte volume, shortened erythrocyte life span, heme and heme precursors degraded from the fetal extramedullary hematopoietic tissue, and, possibly, increased turnover of cytochromes (2). In addition, the ability to conjugate bilirubin is extremely low in the neonate; the B-UGT activity of neonates at term is about 1% of adult values (3). Neonatal hyperbilirubinemia is also probably associated with other factors such as an immaturity of hepatic uptake and intracellular transport, and increased enterohepatic circulation. Thu...